Schizophrenia Research
Volume 91, Issue 1 , Pages 27-36 , March 2007

The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland

  • Joni A. Turunen

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Research Program in Molecular Medicine at Biomedicum Helsinki, Helsinki, Finland
    • These authors contributed equally to this work.
    • ,
  • Juho O. Peltonen

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Research Program in Molecular Medicine at Biomedicum Helsinki, Helsinki, Finland
    • These authors contributed equally to this work.
    • ,
  • Olli P.H. Pietiläinen

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Research Program in Molecular Medicine at Biomedicum Helsinki, Helsinki, Finland
    • ,
  • William Hennah

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Research Program in Molecular Medicine at Biomedicum Helsinki, Helsinki, Finland
    • ,
  • Anu Loukola

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • ,
  • Tiina Paunio

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Department of Psychiatry, Helsinki University Central Hospital, P.O. Box 590, FI-00029, Helsinki, Finland
    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, FI-00300 Helsinki, Finland
    • ,
  • Kaisa Silander

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • ,
  • Jesper Ekelund

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, FI-00300 Helsinki, Finland
    • ,
  • Teppo Varilo

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02139, MA, USA
    • ,
  • Timo Partonen

      Affiliations

    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, FI-00300 Helsinki, Finland
    • ,
  • Jouko Lönnqvist

      Affiliations

    • Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, FI-00300 Helsinki, Finland
    • ,
  • Leena Peltonen

      Affiliations

    • Department of Molecular Medicine, National Public Health Institute, Biomedicum, P.O. Box 104, FI-00251, Helsinki, Finland
    • Research Program in Molecular Medicine at Biomedicum Helsinki, Helsinki, Finland
    • Department of Medical Genetics, University of Helsinki, P.O. Box 63, FI-00014, Helsinki, Finland
    • Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02139, MA, USA
    • Corresponding Author InformationCorresponding author. Department of Molecular Medicine, National Public Health Institute, Biomedicum, Haartmaninkatu 8, FI-00290 Helsinki, Finland. Tel.: +358 9 4744 8393; fax: +358 9 4744 8480.

Received 28 June 2006 ,Revised 26 October 2006 ,Accepted 30 November 2006.

References 

  1. Arajarvi R, Suvisaari J, Suokas J, Schreck M, Haukka J, Hintikka J, et al. Prevalence and diagnosis of schizophrenia based on register, case record and interview data in an isolated Finnish birth cohort born 1940–1969. Soc. Psychiatry Psychiatr. Epidemiol. 2005;40(10):808–816
  2. Arajarvi R, Ukkola J, Haukka J, Suvisaari J, Hintikka J, Partonen T, et al. Psychosis among “healthy” siblings of schizophrenia patients. BMC Psychiatry. 2006;6:6
  3. Bojholm S, Stromgren E. Prevalence of schizophrenia on the island of Bornholm in 1935 and in 1983. Acta Psychiatr. Scand., Suppl. 1989;348:157–166(discussion 167–78)
  4. Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch. Gen. Psychiatry. 1998;55(1):67–74
  5. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, et al Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry. 1999;56(2):162–168
  6. Corvin AP, Morris DW, McGhee K, Schwaiger S, Scully P, Quinn J, et al. Confirmation and refinement of an ‘at-risk’ haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol. Psychiatry. 2004;9(2):208–213
  7. Ekelund J, Lichtermann D, Hovatta I, Ellonen P, Suvisaari J, Terwilliger JD, et al Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum. Mol. Genet. 2000;9(7):1049–1057
  8. Ekelund J, Hovatta I, Parker A, Paunio T, Varilo T, Martin R, et al Chromosome 1 loci in Finnish schizophrenia families. Hum. Mol. Genet. 2001;10(15):1611–1617
  9. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 2004;36(2):131–137
  10. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 2004;36(2):131–137
  11. Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, Kane JM, et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am. J. Hum. Genet. 2004;75(5):891–898
  12. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al The structure of haplotype blocks in the human genome. Science. 2002;296(5576):2225–2229
  13. Gottesman II, Shields J. A critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives. Schizophr. Bull. 1976;2(3):360–401
  14. Hall D, Gogos JA, Karayiorgou M. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav. 2004;3(4):240–248
  15. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry. 2006;60(2):132–140
  16. Hennah W, Varilo T, Kestila M, Paunio T, Arajarvi R, Haukka J, et al Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum. Mol. Genet. 2003;12(23):3151–3159
  17. Hong CJ, Huo SJ, Liao DL, Lee K, Wu JY, Tsai SJ. Case-control and family-based association studies between the neuregulin 1 (Arg38Gln) polymorphism and schizophrenia. Neurosci. Lett. 2004;366(2):158–161
  18. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur. J. Hum. Genet. 2001;9(4):301–306
  19. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet. Epidemiol. 2004;26(1):61–69
  20. Hovatta I, Lichtermann D, Juvonen H, Suvisaari J, Terwilliger JD, Arajarvi R, et al. Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set. Mol. Psychiatry. 1998;3(5):452–457
  21. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, et al. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol. Psychiatry. 2004;56(9):698–700
  22. Isohanni M, Makikyro T, Moring J, Rasanen P, Hakko H, Partanen U, et al. A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia. Soc. Psychiatry Psychiatr. Epidemiol. 1997;32(5):303–308
  23. Iwata N, Suzuki T, Ikeda M, Kitajima T, Yamanouchi Y, Inada T, et al. No association with the neuregulin 1 haplotype to Japanese schizophrenia. Mol. Psychiatry. 2004;9(2):126–127
  24. Kendler KS, Robinette CD. Schizophrenia in the National Academy of Sciences-National Research Council Twin Registry: a 16-year update. Am. J. Psychiatry. 1983;140(12):1551–1563
  25. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch. Gen. Psychiatry. 1993;50(7):527–540
  26. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. III. Schizophrenia-related personality disorders in relatives. Arch. Gen. Psychiatry. 1993;50(10):781–788
  27. Kendler KS, McGuire M, Gruenberg AM, Spellman M, O'Hare A, Walsh D. The Roscommon Family Study. II. The risk of nonschizophrenic nonaffective psychoses in relatives. Arch. Gen. Psychiatry. 1993;50(8):645–652
  28. Li T, Stefansson H, Gudfinnsson E, Cai G, Liu X, Murray RM, et al Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol. Psychiatry. 2004;9(7):698–704
  29. Morris DW, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, et al. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr. Res. 2003;60(2–3):167–172
  30. Munafo MR, Thiselton DL, Clark TG, Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol. Psychiatry. 2006;11(6):539–546
  31. Mäkikyrö T, Isohanni M, Moring J, Hakko H, Hovatta I, Lönnqvist J. Accuracy of register-based schizophrenia diagnoses in a genetic study. Eur. Psychiatr. 1998;13:57–62
  32. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet. 1998;63(1):259–266
  33. Ohtsuki T, Inada T, Arinami T. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol. Psychiatry. 2004;9(11):981–983
  34. Onstad S, Skre I, Torgersen S, Kringlen E. Twin concordance for DSM-III-R schizophrenia. Acta Psychiatr. Scand. 1991;83(5):395–401
  35. Pakaslahti A. On the diagnosis of schizophrenic psychoses in clinical practice. Psychiatr. Fennica. 1987;18:63–72
  36. Paunio T, Ekelund J, Varilo T, Parker A, Hovatta I, Turunen JA, et al Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum. Mol. Genet. 2001;10(26):3037–3048
  37. Petryshen TL, Middleton FA, Kirby A, Aldinger KA, Purcell S, Tahl AR, et al Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol. Psychiatry. 2005;10(4):366–374(328)
  38. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum. Hered. 2000;50(4):211–223
  39. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2(5):e141
  40. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, et al Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 2003;72(1):185–190
  41. Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B, et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol. Psychiatry. 2005;58(6):446–450
  42. Service S, DeYoung J, Karayiorgou M, Roos JL, Pretorious H, Bedoya G, et al Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies. Nat. Genet. 2006;38(5):556–560
  43. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, et al Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002;71(4):877–892
  44. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, et al Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am. J. Hum. Genet. 2003;72(1):83–87
  45. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, et al Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 2002;71(2):337–348
  46. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry. 2003;60(12):1187–1192
  47. Tang JX, Chen WY, He G, Zhou J, Gu NF, Feng GY, et al. Polymorphisms within 5′ end of the neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol. Psychiatry. 2004;9(1):11–12
  48. Thiselton DL, Webb BT, Neale BM, Ribble RC, O'Neill FA, Walsh D, et al. No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Mol. Psychiatry. 2004;9(8):777–783(image 729)
  49. Tienari P, Wynne LC, Moring J, Laksy K, Nieminen P, Sorri A, et al Finnish adoptive family study: sample selection and adoptee DSM-III-R diagnoses. Acta Psychiatr. Scand. 2000;101(6):433–443
  50. Tienari P, Wynne LC, Laksy K, Moring J, Nieminen P, Sorri A, et al. Genetic boundaries of the schizophrenia spectrum: evidence from the Finnish Adoptive Family Study of Schizophrenia. Am. J. Psychiatry. 2003;160(9):1587–1594
  51. Torrey EF. Prevalence studies in schizophrenia. Br. J. Psychiatry. 1987;150:598–608
  52. Tsuang M. Schizophrenia: genes and environment. Biol. Psychiatry. 2000;47(3):210–220
  53. Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S, et al The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am. J. Hum. Genet. 2003;73(6):1438–1443
  54. van den Oord EJ, Sullivan PF, Jiang Y, Walsh D, O'Neill FA, Kendler KS, et al. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol. Psychiatry. 2003;8(5):499–510
  55. Varilo T, Peltonen L. Isolates and their potential use in complex gene mapping efforts. Curr. Opin. Genet. Dev. 2004;14(3):316–323
  56. Williams NM, Preece A, Spurlock G, Norton N, Williams HJ, Zammit S, et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol. Psychiatry. 2003;8(5):485–487
  57. Williams NM, Preece A, Morris DW, Spurlock G, Bray NJ, Stephens M, et al Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch. Gen. Psychiatry. 2004;61(4):336–344
  58. Yang JZ, Si TM, Ruan Y, Ling YS, Han YH, Wang XL, et al Association study of neuregulin 1 gene with schizophrenia. Mol. Psychiatry. 2003;8(7):706–709
  59. Zhao X, Shi Y, Tang J, Tang R, Yu L, Gu N, et al A case control and family based association study of the neuregulin 1 gene and schizophrenia. J. Med. Genet. 2004;41(1):31–34

PII: S0920-9964(06)00502-0

doi: 10.1016/j.schres.2006.11.028

Schizophrenia Research
Volume 91, Issue 1 , Pages 27-36 , March 2007

Article Tools

* Image Usage & Resolution